Copy number analysis of ductal carcinoma in situ with and without recurrence-Reference-Cited by-同舟云学术

Copy number analysis of ductal carcinoma in situ with and without recurrence

Published:2015-06-19 Issue:9 Volume:28 Page:1174-1184
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Gorringe Kylie L^ORCID,Hunter Sally M,Pang Jia-Min,Opeskin Ken,Hill Prue,Rowley Simone M,Choong David Y H,Thompson Ella R,Dobrovic Alexander,Fox Stephen B,Mann G Bruce,Campbell Ian G

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol201575.pdf

Reference43 articles.

1. Sanders ME, Schuyler PA, Dupont WD et al. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 2005;103:2481–2484.

2. Lopez-Garcia MA, Geyer FC, Lacroix-Triki M et al. Breast cancer precursors revisited: molecular features and progression pathways. Histopathology 2010;57:171–192.

3. Leonard GD, Swain SM . Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 2004;96:906–920.

4. Benson JR, Wishart GC . Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery. Lancet Oncol 2013;14:e348–e357.

5. Boxer MM, Delaney GP, Chua BH . A review of the management of ductal carcinoma in situ following breast conserving surgery. Breast 2013;22:1019–1025.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance;Breast Cancer Research;2024-08-27

2. Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment;The Lancet;2024-06

3. Predictive biomarkers of breast ductal carcinomain situmay underestimate the risk of recurrence due tode novoipsilateral breast carcinoma development;2024-05-21

4. Tumor microenvironmental determinants of high-risk DCIS progression;2024-05-09

5. Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance;Signal Transduction and Targeted Therapy;2024-04-03